These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15485598)

  • 1. Antihypertensive drugs and the kidney.
    Nadim MK; Dua R; Campese VM
    Curr Cardiol Rep; 2004 Nov; 6(6):403-8. PubMed ID: 15485598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which antihypertensive drugs are the most nephroprotective and why?
    Cravedi P; Ruggenenti P; Remuzzi G
    Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system.
    Viazzi F; Leoncini G; Pontremoli R
    High Blood Press Cardiovasc Prev; 2013 Dec; 20(4):273-82. PubMed ID: 24092648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of blood pressure reduction for prevention of progression of renal disease.
    Textor SC; Canzanello VJ
    Curr Hypertens Rep; 1999 Oct; 1(5):423-30. PubMed ID: 10981101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection: are all antihypertensive drugs comparable?
    Blake R; Raij L; Hernandez Schulman I
    Curr Hypertens Rep; 2007 Nov; 9(5):373-9. PubMed ID: 18177583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.
    Kaperonis N; Bakris G
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):79-84. PubMed ID: 12496670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protection with angiotensin receptor blockers: where do we stand.
    Schmieder RE; Ruilope LM; Barnett AH
    J Nephrol; 2011; 24(5):569-80. PubMed ID: 21404225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal protection by antihypertensive drugs: insights from microalbuminuria studies.
    Redon J
    J Hypertens; 1998 Dec; 16(12 Pt 2):2091-100. PubMed ID: 9886902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.
    Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; de Jong PE; de Zeeuw D; Shahinfar S; Toto R; Levey AS;
    Ann Intern Med; 2003 Aug; 139(4):244-52. PubMed ID: 12965979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the management of special populations: renal disease in diabetes.
    Raij L
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):46S-49S. PubMed ID: 14625161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.
    Bakris GL; Ritz E;
    Clin Exp Nephrol; 2009 Feb; 13(1):96-9. PubMed ID: 19184272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.